Streptococcus pyogenes or invasive Group A Streptococcus (iGAS) is a major clinical concern around the world, since iGAS infections can quickly escalate into life-threatening conditions such as ...

While the prevalent strains of S. Pyogenes have evolved, the most crucial factors for successful treatment are timely administration of clindomycin and other relevant antibiotics. Streptococcus ...

Griffith University's Institute for Glycomics has developed a groundbreaking, combination vaccine that may finally beat Streptococcus A infections. Human trials are set to begin, early as next year, ...